| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Selling To Vito Is Just Like Selling To Bruno -- Stop Using B2B Sales Closing Techniques |
|
Advice You - Selling To Vito Is Just Like Selling To Bruno -- Stop Using B2B Sales Closing Techniques
Are you a salesperson? Do you use sales closing techniques to land a sale? If you answered yes to these questions According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product you probably can recognize the following sales closing techniques, as popularized by Zig Ziglar:
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ce is ridiculous close
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. li>The persuasion close
Perhaps you're using these sales c here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe losing techniques, yet your sales numbers really aren't that good; the other sales reps in the office have better sales d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro closing ratios, are closing more sales, and are making more money. You may find that odd as you all have access to the s ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc me amount of sales leads. You’re closing by the book yet you're not achieving good numbers. I think I know what your pr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi oblem is… You're using sales closing techniques. STOP!!! Stop using sales closing techniques! The other reps in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically your office most certainly have. Picture this… you are buying a used car and the salesman asks you, "Would you rather t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ke delivery of the car on Wednesday or on Thursday?" What would you do? You would probably think to yourself, "Does this ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi weasel take me for a sucker? He's using the alternate of choice close on me." Do you think that the people you ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a sell to aren't intelligent enough to see through your tactics? They are. They don't want people to use techniques dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod on them. Techniques are for slimy used car salesmen. They want to deal with salespeople that are genuine. And, that's no cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t you if you use sales closing techniques. The way I see it, when selling in B2B, selling to Vito is like selling to Br tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen uno, just as selling to Italians is like selling to Americans. No matter what your name or nationality people buy from p t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ople that they like. That means they buy from genuine people, not people that use sales closing techniques. By the way, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust VITO, as popularized by the book Selling To VITO, is short for "Very Important Top Officer." That means that Vit y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products o, hold a high corporate position, most likely has a high business intelligence. Don't try to use any of your techniques . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on him. He'll see right through you, as would Bruno, Tom, Daniel, Bob, Billy, Scott, or even Sandra for that matter. Ass elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ume everybody is as intelligent as you, be genuine, and you will close more sales without using sales closing techniques tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:CV Writing - How to Write a CV Don't Worry, Bad Service Isn't Going Out of Style Managing for Innovation - Values and Concepts of the Malcolm Baldrige Criteria Part 7
|